Author: Lenka Hajnovicova

Regulatory report: Ecuador

Written by Lenka Hajnovicova || 10th December 2020 || Regulatory reports |

This report provides a detailed overview of the current regulatory regime in place for hemp and CBD in Ecuador, as well as information on medical and recreational cannabis ...

Regulatory report: Japan

Written by Lenka Hajnovicova || 17th September 2020 || Regulatory reports |

This regulatory report covers all aspects of the regulatory regime for hemp and CBD in Japan, including medical cannabis and import/export laws ...

Regulatory report: Uruguay

Written by Lenka Hajnovicova || 15th July 2020 || Regulatory reports |

This report offers a comprehensive overview of the regulatory regime for CBD and cannabis in Uruguay, including rules around extracts, finished products, import/export and medicinal and recreation cannabis ...

Regulatory report: Germany

Written by Lenka Hajnovicova || 8th June 2020 || Regulatory reports |

Medical cannabis is legal in Germany, where domestic cultivation is expected to begin in autumn 2020. This report covers Germany's regulatory regime for cannabis and CBD ...

Regulatory report: Czech Republic

Written by Lenka Hajnovicova || 14th May 2020 || Regulatory reports |

This report offers a thorough overview of the current regulatory regime for CBD in the Czech Republic, covering all aspects from extracts and finished products to medical and recreational cannabis ...

Regulatory report: Colombia

Written by Lenka Hajnovicova || 24th April 2020 || Regulatory reports |

Cultivation of cannabis and manufacture of cannabis-derived products is permitted in Colombia under a licence. This report provides all current regulatory information in place in the country ...

Regulatory report: Mexico

Written by Lenka Hajnovicova || 23rd April 2020 || Regulatory reports |

Cultivation and processing of hemp is currently not allowed in Mexico, however there have been recent proposals for legalisation. This report provides an overview of the current regulatory landscape, as well as likely future regulation ...

CBD considered a medicine: Finland regulatory report

Written by Lenka Hajnovicova || 9th December 2019 || Regulatory reports |

CBD is considered a medicine in Finland and any CBD-infused product, whether for human or animal use, would be classified as a medicinal product. This report provides a comprehensive overview of the regulatory landscape of CBD in Finland...

Slovakia regulatory snapshot, August 2019

Written by Lenka Hajnovicova || 21st August 2019 || Regulatory reports |

Under Slovak law, CBD is classed as a psychotropic substance and as such it cannot be extracted, stored, or used for manufacture of final products without authorisation under the Narcotics Act ...

North Carolina regulatory snapshot

Written by Lenka Hajnovicova || 20th May 2019 || Regulatory reports |

As part of our ongoing series of concise reports on how CBD is regulated across the United States, we look at North Carolina – where changes could be on the horizon ...

Michigan regulatory snapshot

Written by Lenka Hajnovicova || 15th May 2019 || Regulatory reports |

CBD products derived from industrial hemp are legal in the US state of Michigan, subject to certain conditions and regulations, which are explained in this CBD-Intel snapshot ...

Turkey regulatory snapshot

Written by Lenka Hajnovicova || 7th May 2019 || Regulatory reports |

While the regulations governing CBD are extremely harsh, the Turkish government recently announced the launch of hemp cultivation for industrial use on a large scale ...